MX2019001838A - Metodos y composiciones para el tratamiento de verrugas. - Google Patents

Metodos y composiciones para el tratamiento de verrugas.

Info

Publication number
MX2019001838A
MX2019001838A MX2019001838A MX2019001838A MX2019001838A MX 2019001838 A MX2019001838 A MX 2019001838A MX 2019001838 A MX2019001838 A MX 2019001838A MX 2019001838 A MX2019001838 A MX 2019001838A MX 2019001838 A MX2019001838 A MX 2019001838A
Authority
MX
Mexico
Prior art keywords
compositions
warts
treatment
methods
kits
Prior art date
Application number
MX2019001838A
Other languages
English (en)
Inventor
D Shanler Stuart
Beger Brian
Rodney Greenaway Evans Charles
Phillips Christopher
Barry Brown Marc
Powala Christopher
Tiong Lim Sian (Finado)
Original Assignee
Aclaris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aclaris Therapeutics Inc filed Critical Aclaris Therapeutics Inc
Publication of MX2019001838A publication Critical patent/MX2019001838A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Las modalidades están dirigidas a composiciones que comprenden más de 40% p/p hasta aproximadamente 70% p/p de peróxido de hidrógeno estabilizado. La composición también puede incluir un agente modificador de la tensión superficial como 2-propanol. Esas composiciones pueden ser usadas para tratar condiciones como verrugas, condiloma accuminatum, molluscum contagiosum o una combinación de las mismas. Algunas modalidades también describen composiciones para tomarse en casa, composiciones para la oficina o composiciones de venta libre o sin receta y equipos para el uso de esas composiciones.
MX2019001838A 2016-08-17 2017-08-17 Metodos y composiciones para el tratamiento de verrugas. MX2019001838A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662376326P 2016-08-17 2016-08-17
PCT/US2017/047350 WO2018035328A1 (en) 2016-08-17 2017-08-17 Methods and compositions for the treatment of warts

Publications (1)

Publication Number Publication Date
MX2019001838A true MX2019001838A (es) 2019-06-13

Family

ID=61190995

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019001838A MX2019001838A (es) 2016-08-17 2017-08-17 Metodos y composiciones para el tratamiento de verrugas.

Country Status (13)

Country Link
US (1) US20180050009A1 (es)
EP (1) EP3500274A4 (es)
JP (1) JP2019524837A (es)
KR (1) KR20190039575A (es)
CN (1) CN109862898A (es)
AU (1) AU2017312047A1 (es)
BR (1) BR112019003271A2 (es)
CA (1) CA3033669A1 (es)
MX (1) MX2019001838A (es)
RU (1) RU2019107362A (es)
SG (1) SG11201901250PA (es)
WO (1) WO2018035328A1 (es)
ZA (1) ZA201900984B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201608775XA (en) 2014-04-21 2016-11-29 Aclaris Therapeutics Inc Peroxide formulations and methods and applicators for using the same
US20210196676A1 (en) * 2018-05-30 2021-07-01 The Board Of Regents Of The University Of Texas System Treatment of viral infections and virally associated lesions with sequiterpene lactones
CN111249306A (zh) * 2020-01-16 2020-06-09 刘贤贤 一种去除角质的药物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958984A (en) * 1996-10-10 1999-09-28 Devillez; Richard L. Method and composition for skin treatment
US6028104A (en) * 1997-01-30 2000-02-22 Ecolab Inc. Use of peroxygen compounds in the control of hairy wart disease
US20040101571A1 (en) * 2002-09-11 2004-05-27 Pamela Reed Use of hydrogen peroxide for the treatment of warts
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
SG11201608775XA (en) * 2014-04-21 2016-11-29 Aclaris Therapeutics Inc Peroxide formulations and methods and applicators for using the same

Also Published As

Publication number Publication date
WO2018035328A1 (en) 2018-02-22
EP3500274A4 (en) 2020-08-12
SG11201901250PA (en) 2019-03-28
BR112019003271A2 (pt) 2019-06-04
KR20190039575A (ko) 2019-04-12
ZA201900984B (en) 2019-12-18
RU2019107362A (ru) 2020-09-22
JP2019524837A (ja) 2019-09-05
AU2017312047A1 (en) 2019-10-17
CA3033669A1 (en) 2018-02-22
CN109862898A (zh) 2019-06-07
EP3500274A1 (en) 2019-06-26
US20180050009A1 (en) 2018-02-22

Similar Documents

Publication Publication Date Title
MX2016013826A (es) Formulaciones de peroxido y metodos y aplicaciones para utilizarlas.
MX2017013983A (es) Uso de agentes activos durante tratamientos quimicos.
BR112017022021A2 (pt) aplicação de agente anticaspa solúvel em tensoativo
GB2550301A (en) Antimicrobial fibers and compositions
MX2021014709A (es) Composiciones para usarse en el incremento de los niveles de globulos rojos y el tratamiento de enfermedad de celulas falciformes.
MX2021010528A (es) Metodos y composiciones para el tratamiento de las ulceras.
GB2535666A (en) Antimicrobial compositions
MX2009009761A (es) Composiciones y estuches para tratamiento de la influenza.
GB2547402A (en) Prevention and treatment of microbial infections
EA201890641A3 (ru) Стимуляторы sgc
MX2015011898A (es) Compuestos de pirazolo y usos de los mismos.
BR112021025676A2 (pt) Composições e métodos para tratar uma afecção mediada por th2 com o uso de prevotella
MX2019001838A (es) Metodos y composiciones para el tratamiento de verrugas.
MX363408B (es) Composicion que contiene peroxido y acido peracetico y proceso para matar esporas.
BR112012029009A2 (pt) formulações líquidas de fumarato de rupatadina
MX2019008124A (es) Metodos para el tratamiento de trastornos neurologicos.
PH12019501469A1 (en) Compositions and methods for treating biofilms
BR112014026483A2 (pt) composição antimicrobiana, composição antimicrobiana bicomponente, pano de limpeza, método para desinfetar uma superfície e método para controlar esporos sobre uma superfície
MX2019013120A (es) Composicion que contiene dioxido de cloro y metodos para su uso.
RU2012127991A (ru) Способ модифицирования углеродных нанотрубок
MX2014003449A (es) Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel.
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
MX2009004142A (es) Metodo para prevenir o tratar sindrome metabolico.
BR112018067587A2 (pt) método para desinfetar lentes de contato
MX2018002176A (es) Composiciones para aplicaciones topicas que comprenden peroxido de benzoilo y adapaleno.